Breaking News Instant updates and real-time market news.

BNKXF

Bankia

$0.00 /

+ (+0.00%)

15:07
07/29/20
07/29
15:07
07/29/20
15:07

Bankia price target raised to EUR 0.98 from EUR 0.90 at UBS

UBS analyst Ignacio Cerezo raised the firm's price target on Bankia to EUR 0.98 from EUR 0.90 and keeps a Neutral rating on the shares.

BNKXF Bankia
$0.00 /

+ (+0.00%)

07/29/20 Barclays
Bankia price target raised to EUR 1.20 from EUR 1.10 at Barclays
07/29/20 Morgan Stanley
Bankia price target raised to EUR 1.20 from EUR 1.15 at Morgan Stanley
06/18/20 Berenberg
Bankia price target lowered to EUR 0.80 from EUR 0.85 at Berenberg
06/18/20 AlphaValue
Bankia downgraded to Reduce from Buy at AlphaValue

TODAY'S FREE FLY STORIES

Initiation
Zymeworks resumed with a Neutral at JPMorgan » 06:13
09/29/20
09/29
06:13
09/29/20
06:13
ZYME

Zymeworks

$45.04 /

-0.095 (-0.21%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$45.04 /

-0.095 (-0.21%)

ZYME Zymeworks
$45.04 /

-0.095 (-0.21%)

08/06/20
Fly Intel: Top analyst initiations
08/06/20 SVB Leerink
SVB Leerink bullish on Zymeworks, initiates with an Outperform
08/06/20 SVB Leerink
Zymeworks initiated with an Outperform at SVB Leerink
07/14/20 Guggenheim
Zymeworks price target lowered to $48, removed as Best Idea at Guggenheim
ZYME Zymeworks
$45.04 /

-0.095 (-0.21%)

  • 23
    Jan
Initiation
Tricida resumed with an Underweight at JPMorgan » 06:13
09/29/20
09/29
06:13
09/29/20
06:13
TCDA

Tricida

$8.89 /

-0.16 (-1.77%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCDA Tricida
$8.89 /

-0.16 (-1.77%)

TCDA Tricida
$8.89 /

-0.16 (-1.77%)

08/25/20
Fly Intel: Top five analyst downgrades
08/25/20 Needham
Tricida price target lowered to $20 from $44 at Needham
08/25/20 Goldman Sachs
Tricida downgraded to Neutral from Buy at Goldman Sachs
TCDA Tricida
$8.89 /

-0.16 (-1.77%)

TCDA Tricida
$8.89 /

-0.16 (-1.77%)

Initiation
Stoke Therapeutics resumed with a Neutral at JPMorgan » 06:12
09/29/20
09/29
06:12
09/29/20
06:12
STOK

Stoke Therapeutics

$34.77 /

+0.31 (+0.90%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
12/17/19 Wedbush
Stoke Therapeutics initiated with an Outperform at Wedbush
11/12/19
Fly Intel: Top five analyst initiations
11/12/19 BTIG
Stoke Therapeutics initiated with a Buy at BTIG
STOK Stoke Therapeutics
$34.77 /

+0.31 (+0.90%)

Periodicals
Judge says U.S. 'likely exceeded' authority in TikTok ban, WSJ reports » 06:11
09/29/20
09/29
06:11
09/29/20
06:11
ORCL

Oracle

$59.58 /

-0.22 (-0.37%)

, WMT

Walmart

$137.18 /

-0.09 (-0.07%)

A federal judge said the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WMT Walmart
$137.18 /

-0.09 (-0.07%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

09/22/20 Morgan Stanley
Morgan Stanley says hard to tell if TikTok deal true 'thesis-changer' for Oracle
09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 William Blair
TikTok deal 'major coup' for Oracle, says William Blair
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
WMT Walmart
$137.18 /

-0.09 (-0.07%)

09/24/20 SVB Leerink
SVB Leerink bullish on Oak Street Health, initiates with an Outperform
09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/23/20 BWS Financial
Arlo relationship with Walmart not fully realized, says BWS Financial
09/22/20 KeyBanc
Echelon Prime Bike not 'significant impediment' to Peloton growth, says KeyBanc
ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WMT Walmart
$137.18 /

-0.09 (-0.07%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WMT Walmart
$137.18 /

-0.09 (-0.07%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WMT Walmart
$137.18 /

-0.09 (-0.07%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

WMT Walmart
$137.18 /

-0.09 (-0.07%)

Initiation
Radius Health resumed with a Neutral at JPMorgan » 06:11
09/29/20
09/29
06:11
09/29/20
06:11
RDUS

Radius Health

$10.82 /

-0.11 (-1.01%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$10.82 /

-0.11 (-1.01%)

RDUS Radius Health
$10.82 /

-0.11 (-1.01%)

08/11/20 Jefferies
Radius Health price target lowered to $14 from $17 at Jefferies
07/08/20 SVB Leerink
Radius Health downgraded to Market Perform from Outperform at SVB Leerink
05/13/20 Morgan Stanley
Radius Health downgraded to Equal Weight following Q1 report at Morgan Stanley
05/13/20 Morgan Stanley
Radius Health downgraded to Equal Weight from Overweight at Morgan Stanley
RDUS Radius Health
$10.82 /

-0.11 (-1.01%)

Initiation
Mersana Therapeutics resumed with a Neutral at JPMorgan » 06:11
09/29/20
09/29
06:11
09/29/20
06:11
MRSN

Mersana Therapeutics

$19.64 /

+0.21 (+1.08%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRSN Mersana Therapeutics
$19.64 /

+0.21 (+1.08%)

MRSN Mersana Therapeutics
$19.64 /

+0.21 (+1.08%)

06/24/20 BTIG
Mersana Therapeutics price target raised to $32 from $21 at BTIG
05/27/20 H.C. Wainwright
Mersana Therapeutics price target raised to $26 from $13 at H.C. Wainwright
04/29/20 BTIG
Mersana Therapeutics initiated with a Buy at BTIG
01/21/20 H.C. Wainwright
Mersana Therapeutics price target raised to $12 from $7 at H.C. Wainwright
MRSN Mersana Therapeutics
$19.64 /

+0.21 (+1.08%)

  • 29
    May
MRSN Mersana Therapeutics
$19.64 /

+0.21 (+1.08%)

Initiation
ImmunoGen resumed with a Neutral at JPMorgan » 06:10
09/29/20
09/29
06:10
09/29/20
06:10
IMGN

ImmunoGen

$3.58 /

-0.1 (-2.72%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMGN ImmunoGen
$3.58 /

-0.1 (-2.72%)

IMGN ImmunoGen
$3.58 /

-0.1 (-2.72%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
05/04/20 H.C. Wainwright
ImmunoGen shares offer 'compelling entry point,' says H.C. Wainwright
12/17/19 H.C. Wainwright
ImmunoGen price target hiked to $9 after 'compelling' advance at H.C. Wainwright
09/29/19 Piper Jaffray
Biomarker screening reason for ImmunoGen FORWARD I failure, says Piper Jaffray
IMGN ImmunoGen
$3.58 /

-0.1 (-2.72%)

  • 21
    Jan
IMGN ImmunoGen
$3.58 /

-0.1 (-2.72%)

Initiation
Esperion resumed with an Underweight at JPMorgan » 06:10
09/29/20
09/29
06:10
09/29/20
06:10
ESPR

Esperion

$37.14 /

-0.4 (-1.07%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESPR Esperion
$37.14 /

-0.4 (-1.07%)

ESPR Esperion
$37.14 /

-0.4 (-1.07%)

08/10/20 Credit Suisse
Esperion downgraded to Neutral from Outperform at Credit Suisse
05/07/20 Citi
Esperion price target raised to $56 from $46 at Citi
04/20/20 JMP Securities
JMP reiterates $191 price target on Esperion after Japan partnership
04/16/20 Northland
Esperion price target lowered to $42 from $60 at Northland
ESPR Esperion
$37.14 /

-0.4 (-1.07%)

ESPR Esperion
$37.14 /

-0.4 (-1.07%)

ESPR Esperion
$37.14 /

-0.4 (-1.07%)

Initiation
BioCryst resumed with an Overweight at JPMorgan » 06:09
09/29/20
09/29
06:09
09/29/20
06:09
BCRX

BioCryst

$3.67 /

+0.03 (+0.82%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$3.67 /

+0.03 (+0.82%)

BCRX BioCryst
$3.67 /

+0.03 (+0.82%)

06/26/20 JMP Securities
BioCryst price target raised to $11 from $10 at JMP Securities
06/16/20 BTIG
BioCryst initiated with a Neutral at BTIG
05/06/20 JMP Securities
BioCryst has potential best-in-class PNH treatment, says JMP Securities
05/06/20 Piper Sandler
BioCryst price target raised to $10 from $8 at Piper Sandler
BCRX BioCryst
$3.67 /

+0.03 (+0.82%)

  • 28
    May
  • 14
    Nov
BCRX BioCryst
$3.67 /

+0.03 (+0.82%)

BCRX BioCryst
$3.67 /

+0.03 (+0.82%)

Periodicals
Disney sells ad tech company TrueX to Gimbal, WSJ reports » 06:08
09/29/20
09/29
06:08
09/29/20
06:08
DIS

Disney

$126.00 /

+1.96 (+1.58%)

Disney has sold ad tech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$126.00 /

+1.96 (+1.58%)

DIS Disney
$126.00 /

+1.96 (+1.58%)

09/28/20 Benchmark
Benchmark says market continues overestimating Netflix's 'sustainable dominance'
09/24/20 Needham
Disney Q4 revenue, earnings outlook lowered at Needham
09/14/20 Jefferies
ESPN deal positive for both Caesars and DraftKings, says Jefferies
09/14/20 Evercore ISI
ESPN deal could add up to material dollars for DraftKings, says Evercore
DIS Disney
$126.00 /

+1.96 (+1.58%)

DIS Disney
$126.00 /

+1.96 (+1.58%)

DIS Disney
$126.00 /

+1.96 (+1.58%)

DIS Disney
$126.00 /

+1.96 (+1.58%)

Initiation
Aprea Therapeutics resumed with a Neutral at JPMorgan » 06:08
09/29/20
09/29
06:08
09/29/20
06:08
APRE

Aprea Therapeutics

$22.59 /

-0.81 (-3.46%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APRE Aprea Therapeutics
$22.59 /

-0.81 (-3.46%)

APRE Aprea Therapeutics
$22.59 /

-0.81 (-3.46%)

06/22/20
Fly Intel: Top five analyst initiations
06/22/20 H.C. Wainwright
Aprea Therapeutics initiated with a Neutral at H.C. Wainwright
04/21/20
Fly Intel: Top five analyst initiations
04/20/20
Baird starts Aprea Therapeutics with Outperform on APR-246 potential
APRE Aprea Therapeutics
$22.59 /

-0.81 (-3.46%)

  • 03
    Oct
APRE Aprea Therapeutics
$22.59 /

-0.81 (-3.46%)

Initiation
Amarin resumed with a Neutral at JPMorgan » 06:07
09/29/20
09/29
06:07
09/29/20
06:07
AMRN

Amarin

$4.00 /

+0.175 (+4.58%)

JPMorgan analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMRN Amarin
$4.00 /

+0.175 (+4.58%)

AMRN Amarin
$4.00 /

+0.175 (+4.58%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMRN Amarin
$4.00 /

+0.175 (+4.58%)

AMRN Amarin
$4.00 /

+0.175 (+4.58%)

AMRN Amarin
$4.00 /

+0.175 (+4.58%)

AMRN Amarin
$4.00 /

+0.175 (+4.58%)

Hot Stocks
IHS Markit says 'exiting the year in good position to achieve our 2021 outlook' » 06:07
09/29/20
09/29
06:07
09/29/20
06:07
INFO

IHS Markit

$80.00 /

+2.25 (+2.89%)

"In Q3, we delivered…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFO IHS Markit
$80.00 /

+2.25 (+2.89%)

INFO IHS Markit
$80.00 /

+2.25 (+2.89%)

06/24/20 Baird
IHS Markit price target raised to $84 from $69 at Baird
06/24/20 Wells Fargo
IHS Markit price target raised to $90 from $70 at Wells Fargo
06/24/20 BMO Capital
IHS Markit price target raised to $82 from $62 at BMO Capital
06/24/20 RBC Capital
IHS Markit price target raised to $90 from $84 at RBC Capital
INFO IHS Markit
$80.00 /

+2.25 (+2.89%)

Hot Stocks
Microsoft Outlook, Office 365, Teams back for most users following outage » 06:06
09/29/20
09/29
06:06
09/29/20
06:06
MSFT

Microsoft

$209.69 /

+1.94 (+0.93%)

Some Microsoft services,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

09/24/20 Lynx
Microsoft's Bethesda deal positive for AMD, says Lynx
09/24/20 Jefferies
Jefferies 'overwhelmed' by announcements and innovation at Microsoft Ignite
09/23/20 Colliers
Harmonic opportunity in focus after SES partners with Microsoft, says Colliers
09/23/20 Baird
Demand for PS5, Xbox Series X continues to look 'strong,' says Baird
MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

MSFT Microsoft
$209.69 /

+1.94 (+0.93%)

Hot Stocks
IHS Markit reports Q3 cash flow from operations of $403M, free cash flow $339M  06:06
09/29/20
09/29
06:06
09/29/20
06:06
INFO

IHS Markit

$80.00 /

+2.25 (+2.89%)

 
ShowHide Related Items >><<
INFO IHS Markit
$80.00 /

+2.25 (+2.89%)

INFO IHS Markit
$80.00 /

+2.25 (+2.89%)

06/24/20 Baird
IHS Markit price target raised to $84 from $69 at Baird
06/24/20 Wells Fargo
IHS Markit price target raised to $90 from $70 at Wells Fargo
06/24/20 BMO Capital
IHS Markit price target raised to $82 from $62 at BMO Capital
06/24/20 RBC Capital
IHS Markit price target raised to $90 from $84 at RBC Capital
INFO IHS Markit
$80.00 /

+2.25 (+2.89%)

Hot Stocks
Oracle, Zoom Video announce integrations for customer experience » 06:06
09/29/20
09/29
06:06
09/29/20
06:06
ORCL

Oracle

$59.58 /

-0.22 (-0.37%)

, ZM

Zoom Video

$487.86 /

-8.635 (-1.74%)

Oracle (ORCL) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$59.58 /

-0.22 (-0.37%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

09/22/20 Morgan Stanley
Morgan Stanley says hard to tell if TikTok deal true 'thesis-changer' for Oracle
09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 William Blair
TikTok deal 'major coup' for Oracle, says William Blair
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

09/28/20 Morgan Stanley
Morgan Stanley leans 'more cautious' on Zoom with shares 'priced for perfection'
09/21/20 Summit Insights
Snowflake initiated with a Sell at Summit Insights
09/14/20 Baird
Zoom Video still in early innings of market penetration, says Baird
09/03/20 Needham
Crowdstrike price target raised to $170 from $120 at Needham
ORCL Oracle
$59.58 /

-0.22 (-0.37%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

ORCL Oracle
$59.58 /

-0.22 (-0.37%)

ZM Zoom Video
$487.86 /

-8.635 (-1.74%)

Hot Stocks
Radware, Bharti Airtel announce partnership » 06:05
09/29/20
09/29
06:05
09/29/20
06:05
RDWR

Radware

$24.64 /

+0.47 (+1.94%)

Radware and Bharti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDWR Radware
$24.64 /

+0.47 (+1.94%)

RDWR Radware
$24.64 /

+0.47 (+1.94%)

04/01/20 Berenberg
Radware downgraded to Hold from Buy at Berenberg
02/13/20 Needham
Radware downgraded to Hold from Buy at Needham
02/13/20 Needham
Radware downgraded to Hold from Buy at Needham
RDWR Radware
$24.64 /

+0.47 (+1.94%)

Downgrade
RLJ Lodging Trust downgraded to Underperform from Neutral at BofA » 06:05
09/29/20
09/29
06:05
09/29/20
06:05
RLJ

RLJ Lodging Trust

$8.94 /

+0.44 (+5.18%)

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RLJ RLJ Lodging Trust
$8.94 /

+0.44 (+5.18%)

RLJ RLJ Lodging Trust
$8.94 /

+0.44 (+5.18%)

07/24/20 SunTrust
RLJ Lodging Trust upgraded to Hold from Sell at SunTrust
07/24/20 SunTrust
RLJ Lodging Trust upgraded to Hold from Sell at SunTrust
06/29/20 Capital One
RLJ Lodging Trust upgraded to Overweight from Equalweight at Capital One
06/22/20 Barclays
RLJ Lodging Trust price target raised to $11 from $9 at Barclays
RLJ RLJ Lodging Trust
$8.94 /

+0.44 (+5.18%)

Upgrade
Pebblebrook Hotel upgraded to Buy from Neutral at BofA » 06:05
09/29/20
09/29
06:05
09/29/20
06:05
PEB

Pebblebrook Hotel

/

+

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEB Pebblebrook Hotel
/

+

PEB Pebblebrook Hotel
/

+

09/21/20 Citi
Pebblebrook Hotel price target raised to $11.50 from $8.50 at Citi
07/07/20 BTIG
Pebblebrook Hotels, Host Hotels price targets lowered at BTIG
06/22/20 Barclays
Pebblebrook upgraded to Equal Weight with $15 target at Barclays
06/22/20 Barclays
Pebblebrook Hotel upgraded to Equal Weight from Underweight at Barclays
PEB Pebblebrook Hotel
/

+

Upgrade
Sunstone Hotel upgraded to Buy from Neutral at BofA » 06:05
09/29/20
09/29
06:05
09/29/20
06:05
SHO

Sunstone Hotel

/

+

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHO Sunstone Hotel
/

+

SHO Sunstone Hotel
/

+

08/10/20 Evercore ISI
Sunstone Hotel upgraded to Outperform from In Line at Evercore ISI
07/29/20 Morgan Stanley
Morgan Stanley upgrades Sunstone Hotel to Equal Weight after underperformance
07/29/20 Morgan Stanley
Morgan Stanley upgrades Host Hotels to Equal Weight following underperformance
07/29/20 Morgan Stanley
Sunstone Hotel upgraded to Equal Weight from Underweight at Morgan Stanley
SHO Sunstone Hotel
/

+

SHO Sunstone Hotel
/

+

Upgrade
Park Hotels & Resorts upgraded to Buy from Underperform at BofA » 06:05
09/29/20
09/29
06:05
09/29/20
06:05
PK

Park Hotels & Resorts

/

+

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PK Park Hotels & Resorts
/

+

PK Park Hotels & Resorts
/

+

09/21/20 Citi
Park Hotels & Resorts price target raised to $9.25 from $6.50 at Citi
09/10/20
Fly Intel: Top five analyst upgrades
09/10/20 Wells Fargo
Park Hotels upgraded to Equal Weight with $11 target at Wells Fargo
09/10/20 Wells Fargo
Park Hotels & Resorts upgraded to Equal Weight from Underweight at Wells Fargo
PK Park Hotels & Resorts
/

+

PK Park Hotels & Resorts
/

+

PK Park Hotels & Resorts
/

+

Downgrade
Host Hotels downgraded to Underperform from Neutral at BofA » 06:04
09/29/20
09/29
06:04
09/29/20
06:04
HST

Host Hotels

$10.93 /

+0.29 (+2.73%)

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HST Host Hotels
$10.93 /

+0.29 (+2.73%)

HST Host Hotels
$10.93 /

+0.29 (+2.73%)

07/29/20 Morgan Stanley
Morgan Stanley upgrades Sunstone Hotel to Equal Weight after underperformance
07/29/20 Morgan Stanley
Morgan Stanley upgrades Host Hotels to Equal Weight following underperformance
07/29/20 Morgan Stanley
Host Hotels upgraded to Equal Weight from Underweight at Morgan Stanley
07/24/20 SunTrust
SunTrust cuts lodging REITs to Sell, Park Hotels double-downgraded from Buy
HST Host Hotels
$10.93 /

+0.29 (+2.73%)

HST Host Hotels
$10.93 /

+0.29 (+2.73%)

HST Host Hotels
$10.93 /

+0.29 (+2.73%)

Upgrade
Extended Stay America upgraded to Buy from Neutral at BofA » 06:04
09/29/20
09/29
06:04
09/29/20
06:04
STAY

Extended Stay America

/

+

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STAY Extended Stay America
/

+

STAY Extended Stay America
/

+

06/22/20 Barclays
Barclays upgrades DiamondRock on 'drive-to' resort exposure
06/02/20 Jefferies
Extended Stay America should outperform peers near and long-term, says Jefferies
04/22/20
Fly Intel: Top five analyst upgrades
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
STAY Extended Stay America
/

+

STAY Extended Stay America
/

+

STAY Extended Stay America
/

+

Downgrade
Choice Hotels downgraded to Underperform from Neutral at BofA » 06:04
09/29/20
09/29
06:04
09/29/20
06:04
CHH

Choice Hotels

$88.26 /

+1.94 (+2.25%)

BofA analyst Shaun Kelley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHH Choice Hotels
$88.26 /

+1.94 (+2.25%)

CHH Choice Hotels
$88.26 /

+1.94 (+2.25%)

09/28/20 Longbow
Choice Hotels downgraded to Neutral from Buy at Longbow
08/21/20 Wells Fargo
Choice Hotels price target raised to $104 from $95 at Wells Fargo
07/14/20 JPMorgan
Too early to turn bullish on Lodging stocks, says JPMorgan
06/25/20 Gordon Haskett
Choice Hotels initiated with a Hold at Gordon Haskett
CHH Choice Hotels
$88.26 /

+1.94 (+2.25%)

CHH Choice Hotels
$88.26 /

+1.94 (+2.25%)

CHH Choice Hotels
$88.26 /

+1.94 (+2.25%)

Initiation
Axsome Therapeutics initiated with an Underperform at BofA » 06:04
09/29/20
09/29
06:04
09/29/20
06:04
AXSM

Axsome Therapeutics

$76.45 /

-0.51 (-0.66%)

BofA initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

09/10/20 Morgan Stanley
Axsome Therapeutics initiated with an Overweight at Morgan Stanley
09/01/20 Guggenheim
Axsome's Alzheimer's agitation update better than expected, says Guggenheim
07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

  • 19
    Dec
AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

AXSM Axsome Therapeutics
$76.45 /

-0.51 (-0.66%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.